Pages

Friday, October 12, 2007

2007 BIO InvestorForum -

2007 BIO InvestorForum -: "The annual biotechnology investor conference featuring private and small to mid-cap public growth companies. October 9-11, 2007 Palace Hotel, San Francisco.

Save the Date
BIO InvestorForum 2007
October 9 - 11, 2007
Palace Hotel
San Francisco

Background: The 4th Annual BIO Investor Forum will showcase to the investment community public and venture-stage growth companies as well as those poised to join the growth “watch list” in the coming year.

Highlights:
  • Over 235 public and venture-stage company presentations
  • Eight therapeutic workshops focusing on drug and technology developments
  • Six business roundtables focusing on the latest market and investment opportunities
  • One-on-One investor meetings
  • Networking with top industry executives and investors focused exclusively on life sciences Request a Presentation Slot Please check back as more information becomes available."

About BIO

Leadership
BIO works hand in hand with industry leaders to enable the organization to provide a singular voice and united policy focus for our membership. We take the lead in Washington, D.C., and state capitals and the national and local media, so that BIO members can focus on what they do best - develop new products to improve the quality of life.

Access
BIO membership opens doors you need to open - in places where you need access - through investment and partnering events, and industry-wide networking and marketing opportunities. And as you grow, BIO grows, with new programs, more impact and increased involvement.

Advocacy
As the world's largest organization representing the biotech industry, BIO is the call politicians, regulators and reporters make for knowledge and credibility. Through BIO, our members get promoted, get marketed and get things done. BIO is the recognized voice to the national media on your issues.

BIO provides aggressive advocacy in the halls of Congress and the White House for priority member issues such as tax reforms for biotech research, Medicare coverage of biotech drugs, and strong patent protection for innovative biotech products.

Intelligence
BIO develops timely and useful publications that are available to members only. We reach more then 500,000 industry professionals with BIO News, BIO Bulletins, the BIO Membership Directory, BIO Annual Report, and the Editors' & Reporters' Guide. And www.bio.org is the hub for the biotechnology industry, with ever-increasing opportunities for marketing and exposure.

Helge: Take a look at the participating companies.


Post a Comment